Wipro Consumer Care to buy 60% of DERMATOUCH at ₹387.5 crore enterprise value

Wipro Consumer Care & Lighting will acquire a 60% stake in digital-first premium skincare brand DERMATOUCH. It plans to buy the remaining 40% over the next three years; DERMATOUCH reported FY26 revenue of ₹131 crore, up 114% year on year.

— Source published Tue, 18 Aug, 2026, 16:38 IST · First seen Tue, 18 Aug, 2026, 16:44 IST · Source Business Standard · Companies

What happened

Wipro Consumer Care & Lighting will acquire a 60% stake in premium skincare brand DERMATOUCH at a ₹387.5 crore enterprise value, with full ownership planned

Key facts

  • 60% stake
  • ₹387.5 crore enterprise value
  • remaining 40% acquisition over next three years
  • 18th acquisition
  • DERMATOUCH FY26 revenue: ₹131 crore
  • 114% FY25 revenue growth

Why this matters

The 60% acquisition with a planned buyout of the remaining stake over three years gives Wipro control now while staging valuation, integration and founder-retention risk.

What to watch

  • DERMATOUCH's FY27 revenue growth rate, repeat purchase trends and contribution-margin trajectory after the investment.
  • Offline channel mix and whether pharmacy/modern-trade expansion grows incremental demand rather than cannibalizing marketplace sales.
  • Founders' continued operating role and the terms or performance benchmarks tied to Wipro's purchase of the remaining 40%.
  • New product-launch cadence, clinical claims compliance and dermatologist endorsement strength.
  • Competitive responses from HUL, Nykaa, Honasa, L'Oréal, Beiersdorf, Kaya and fast-growing Indian D2C skincare brands.
  • Evidence of Wipro using DERMATOUCH as a platform for further beauty and personal-care acquisitions.
  • Accelerate offline entry through dermatologists, pharmacies, premium beauty retail, modern trade and selectively curated general trade.
  • Fund new science-backed SKUs in high-repeat categories such as acne, pigmentation, barrier repair, sunscreen and hair/scalp care.
  • Use Wipro's procurement, manufacturing and distribution infrastructure to improve gross margin and reduce stock-outs without changing premium formulations.
  • Preserve a standalone digital brand team while adding governance milestones that inform the valuation and timing of the remaining 40% acquisition.
  • Increase influencer, dermatologist and content-led education spend, while shifting measurement toward repeat purchase, contribution margin and cohort profitability.
  • Explore export expansion in South Asia, the Gulf and other markets where Indian dermatology-led skincare has demand.

Also reported by